[Therapeutic strategy and long-term prognosis of acute coronary syndrome]

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Coronary Syndromes

Context:

• Acute coronary syndrome (ACS) management requires understanding the link between initial treatment and long-term patient outcomes.
• Q-wave myocardial infarction (MI) benefits significantly from timely reperfusion, with earlier intervention correlating to better prognosis.
• Non-Q-wave MI and unstable angina present complex lesions, often with thrombi, necessitating careful therapeutic strategy selection.

Purpose:

• To review the relationship between initial therapeutic strategies and the long-term prognosis in patients diagnosed with acute coronary syndrome.
• To evaluate the effectiveness of reperfusion therapies, specifically comparing direct percutaneous coronary intervention (PTCA) with thrombolytic therapy.
• To assess the optimal timing and approach for interventions in non-Q-wave MI and unstable angina.

Summary:

• For Q-wave infarction, early reperfusion is critical, with TIMI 3 flow post-intervention significantly improving long-term prognosis.
• Direct PTCA demonstrates superior outcomes compared to thrombolytic therapy, including lower mortality, reocclusion, and cerebrovascular accident rates.
• For non-Q-wave MI and unstable angina, a conservative strategy allowing plaque stabilization before intervention is often recommended due to lesion instability.

Impact:

• Findings support direct PTCA as a preferred reperfusion strategy for Q-wave MI, enhancing long-term patient survival and reducing complications.
• The study highlights the need for individualized treatment plans based on ACS subtype, balancing immediate intervention with potential plaque stabilization.
• Understanding early outcomes is crucial for predicting the long-term prognosis of unstable angina, guiding clinical decision-making.